Premium
Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13 C‐labeled peptide standards
Author(s) -
Kuhn Eric,
Wu Jiang,
Karl Johann,
Liao Hua,
Zolg Werner,
Guild Brad
Publication year - 2004
Publication title -
proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.26
H-Index - 167
eISSN - 1615-9861
pISSN - 1615-9853
DOI - 10.1002/pmic.200300670
Subject(s) - chemistry , chromatography , selected reaction monitoring , mass spectrometry , immunoassay , blood proteins , tandem mass spectrometry , quantitative proteomics , antibody , proteomics , biochemistry , biology , immunology , gene
Abstract A general method for the quantification of proteins in human serum was developed using mass spectrometry (MS) and stable isotope‐labeled synthetic peptides as internal standards. Using this approach, C‐reactive protein (CRP), a diagnostic marker of rheumatoid arthritis (RA), was detected in serum samples taken from patients with either erosive or nonerosive RA and compared to healthy individuals. Small volumes of serum samples were enriched for low‐abundance proteins through the selective removal of human serum albumin (HSA), immunoglobulin G (IgG), and haptoglobin. After depletion of abundant proteins, the complexity of the protein mixture was further simplified using size exclusion chromatography (SEC) to fractionate denatured proteins into discrete molecular weight ranges. Fractions of interest containing CRP, M r = 25 000, were pooled, digested with trypsin, and then fixed quantities of the synthetic peptides were added to the mixture. The mixture of tryptic peptides was subsequently analyzed by nanoflow chromatography‐tandem MS (nanoLC‐MS/MS) using multiple‐reaction monitoring (MRM) on a triple quadrupole mass spectrometer (TQ‐MS). The ratio of transition ions derived from the endogenous and isotope‐labeled peptides provided a quantitative measure of CRP in the original samples as assessed by independent measurement of CRP in the same patient samples using an immunoassay. The use of isotope‐labeled synthetic peptides and MRM is a powerful analytical method for the prescreening of candidate protein biomarkers in human serum prior to antibody and immunoassay development.